C-Rad AB (publ) (CRAD_B) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you and good morning, everyone. Welcome to CIRAD's presentation of our results for the fourth quarter and full year 2025. I am Thomas Blomqvist, CEO of CIRAD, and joining me today is our CFO, Linda Frulén. I will begin with a brief introduction and perspective. After that, Linda will walk through the financial and regional performance, and we will then open up the call for a Q&A session. This is my ninth day and first quarterly webcast as CEO of CIRAD, and I would like to begin by saying that I'm very happy and humbled to take on this role. I also would like to thank the board for its confidence, and I want to express my sincere appreciation to our interim leadership team, Linda Furlén, Johan Danielsson, and board member Peter Simonsbacka for their disciplined and professional leadership during the transition. Their work ensures stability and continuity and provides a strong foundation as we move into the next phase of CRAT's development. For those of you who do not know me, I have spent more than 30 years in life science, diagnostics and medtech, including over two decades in global leadership roles and five years as the CEO of a NASDAQ-listed large-cap company. Throughout my career, my focus has been on building profitable growth companies with exceptional people through clear priorities, strong execution and high performance cultures. What attracted me to C-Rad was the combination of clinically relevant technology, a growing end market and solid fundamentals, including a strong balance sheet, stable gross margins and a committed organization and board. My leadership philosophy is pragmatic and execution driven. I believe in clarity, accountability and teamwork built on trust. High performing organizations are created when expectations are clear, responsibili...